Research explained
Lose the weight. Keep everything else.
A new study of 59,269 adults found that the share of your body that's lean tracks with metabolic health better than the total. Here's what that means if you're losing weight on a GLP-1.
Medically reviewed by Mark Nessim, MD, board-certified anesthesiologist · Last updated
Who publishes this: Habthera Nutrition, which makes ASP-1, a protein supplement. Where our product appears it is labeled as ours. Editorial policy.
The short answer
A new study of 59,269 adults found something that sounds backwards at first: people with more total fat-free mass, the muscle, bone, organs and water that make up everything that isn't fat, were more likely to have metabolic syndrome and raised blood sugar. But people with a higher proportion of their body weight made up of fat-free mass were less likely to have them.[1][2]
The researchers are clear that this does not mean muscle is bad for you. It means the number that matters is the share, not the kilograms, and that where fat sits in the body changes the picture.[2] If you are losing weight on a GLP-1, that is a useful way to think about what you're trying to keep.
What the study did
The team, from Pennington Biomedical Research Center in Baton Rouge (Sri Lakshmi S. Devarakonda, Dachuan Zhang, Reilly Roberts and Candida Rebello), used body-composition scans from the UK Biobank: DXA, the same kind of scan used in the GLP-1 drug trials, and MRI. They compared those measurements with two outcomes: metabolic syndrome, the cluster of high waist size, blood pressure, triglycerides and blood sugar with low HDL cholesterol, and elevated HbA1c, the three-month blood-sugar test. The paper appears in The Journal of Clinical Endocrinology & Metabolism.[1][2]
The result depended on how fat-free mass was counted:[2][3]
Why the split? A likely part of the answer is body size. A larger body carries more of everything: more fat, and also more muscle to move it, bigger organs and more water. So a big absolute fat-free mass can travel with a lot of fat. The proportion strips that out and asks how much of the body is lean tissue.
The researchers also looked at visceral fat, the deep abdominal fat packed around the organs, and fat infiltrating muscle, and concluded that fat distribution shapes the relationship between fat-free mass and metabolic health.[2] "Where fat is stored in the body is an important part of the story," said Devarakonda, the first author. Rebello, the senior author, said researchers "need to look beyond the amount of fat-free mass a person has."[2]
The team also examined whether sex hormones influenced these relationships. The press materials we could read don't report that result, so we haven't summarized it here.
This is an observational study: it finds associations, not cause and effect. UK Biobank participants are mostly middle-aged and older adults in the UK, and the study was not about people taking GLP-1 medications or losing weight. Read it as a better way to frame the goal, not as proof of what weight loss does.
If you're on a GLP-1
Weight loss on a GLP-1 is mostly fat, but not all of it. In the drug trials' DXA sub-studies, lean mass was roughly a quarter to two-fifths of the weight lost: about 38% on semaglutide in STEP 1 and about 26% on tirzepatide in SURMOUNT-1.[4][5] DXA "lean" includes water and organs, so the muscle share is lower than that. And because fat falls faster than lean, the proportion of body weight that is lean usually goes up even while the absolute amount goes down. In STEP 1 it rose by about 3 percentage points.[4] More on those numbers in our muscle-loss guide.
That reframes success. The scale tells you how much weight left. What you want to know is what's left behind, and the aim is that as much of it as possible is muscle. Two habits do most of the work:
No. The researchers say their results do not mean muscle or fat-free mass is harmful. Higher total fat-free mass was associated with more metabolic syndrome largely because bigger bodies carry more of everything, including fat. A higher share of body weight as fat-free mass was associated with less metabolic syndrome and lower HbA1c.
In 59,269 UK Biobank participants measured with DXA and MRI, higher total and height-adjusted fat-free mass were associated with more metabolic syndrome and higher HbA1c, while a higher proportion of body weight as fat-free mass was associated with less. Visceral fat and fat inside muscle shaped the relationship. It was published in The Journal of Clinical Endocrinology & Metabolism in 2026.
The study did not look at GLP-1 medications. In the drug trials, some of the weight lost was lean mass, but because fat falls faster, the share of body weight that is lean usually rises. Protein and resistance training help keep as much lean tissue as possible.
Eat protein first at every meal, aiming for roughly 1.2 to 1.6 grams per kilogram of body weight a day during weight loss, and do resistance training two to three times a week from the start. Track strength and waist size, not just the scale.
Keep reading